[HTML][HTML] A comprehensive comparison between camelid nanobodies and single chain variable fragments
Y Asaadi, FF Jouneghani, S Janani… - Biomarker Research, 2021 - Springer
By the emergence of recombinant DNA technology, many antibody fragments have been
developed devoid of undesired properties of natural immunoglobulins. Among them …
developed devoid of undesired properties of natural immunoglobulins. Among them …
Towards development of biobetter: L-asparaginase a case study
Background L-asparaginase (ASNase) has played a key role in the management of acute
lymphoblastic leukaemia (ALL). As an amidohydrolase, it catalyzes the hydrolysis of L …
lymphoblastic leukaemia (ALL). As an amidohydrolase, it catalyzes the hydrolysis of L …
[HTML][HTML] Circumvention of common labelling artefacts using secondary nanobodies
S Sograte-Idrissi, T Schlichthaerle, CJ Duque-Afonso… - Nanoscale, 2020 - pubs.rsc.org
A standard procedure to study cellular elements is via immunostaining followed by optical
imaging. This methodology typically requires target-specific primary antibodies (1. Abs) …
imaging. This methodology typically requires target-specific primary antibodies (1. Abs) …
[HTML][HTML] α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice
YR Butler, Y Liu, R Kumbhar, P Zhao… - Nature …, 2022 - nature.com
Pathogenic α-synuclein (α-syn) is a prion-like protein that drives the pathogenesis of Lewy
Body Dementia (LBD) and Parkinson's Disease (PD). To target pathogenic α-syn preformed …
Body Dementia (LBD) and Parkinson's Disease (PD). To target pathogenic α-syn preformed …
[HTML][HTML] Camelid VHHs fused to human fc fragments provide long term protection against botulinum neurotoxin a in mice
SA Godakova, AN Noskov, ID Vinogradova… - Toxins, 2019 - mdpi.com
The bacterium Clostridium botulinum is the causative agent of botulism—a severe
intoxication caused by botulinum neurotoxin (BoNT) and characterized by damage to the …
intoxication caused by botulinum neurotoxin (BoNT) and characterized by damage to the …
Polylactic-co-glycolic acid-based nanoparticles modified with peptides and other linkers cross the blood–brain barrier for targeted drug delivery
Y Na, N Zhang, X Zhong, J Gu, C Yan, S Yin, X Lei… - …, 2023 - Taylor & Francis
Because of the blood–brain barrier, only a limited fraction of drugs can penetrate the brain.
As a result, there is a need to take larger doses of the drug, which may result in numerous …
As a result, there is a need to take larger doses of the drug, which may result in numerous …
Protein encapsulation of nanocatalysts: A feasible approach to facilitate catalytic theranostics
D Jin, M Liu, M Zhang, W Yu, J Yu, A Shen… - Advanced Drug Delivery …, 2023 - Elsevier
Enzyme-mimicking nanocatalysts, also termed nanozymes, have attracted much attention in
recent years. They are considered potential alternatives to natural enzymes due to their …
recent years. They are considered potential alternatives to natural enzymes due to their …
FluoSTEPs: Fluorescent biosensors for monitoring compartmentalized signaling within endogenous microdomains
Growing evidence suggests that many essential intracellular signaling events are
compartmentalized within kinetically distinct microdomains in cells. Genetically encoded …
compartmentalized within kinetically distinct microdomains in cells. Genetically encoded …
Production of recombinant scorpion antivenoms in E. coli: current state and perspectives
SM Alonso Villela, H Kraïem-Ghezal… - Applied Microbiology …, 2023 - Springer
Scorpion envenomation is a serious health problem in tropical and subtropical zones. The
access to scorpion antivenom is sometimes limited in availability and specificity. The …
access to scorpion antivenom is sometimes limited in availability and specificity. The …
Driving CARs with alternative navigation tools–the potential of engineered binding scaffolds
T cells that are genetically engineered to express chimeric antigen receptors (CAR T cells)
have shown impressive clinical efficacy against B‐cell malignancies. In contrast to these …
have shown impressive clinical efficacy against B‐cell malignancies. In contrast to these …